Detalhe da pesquisa
1.
Real-World Disease Burden and Healthcare Resource Utilization Among Patients with COPD and Asthma Using Triple Therapy (FF/UMEC/VI) in the United States.
Int J Chron Obstruct Pulmon Dis
; 19: 281-296, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38292138
2.
Outcomes of Patients with COPD Treated with ICS/LABA Before and After Initiation of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI).
Adv Ther
; 41(3): 1245-1261, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310193